These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 3437794

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M, Jimenez J, Porres JC, Bartolomé J, Moreno A, Carreño V.
    Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
    [Abstract] [Full Text] [Related]

  • 3. A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
    Carreño V, Porres JC, Mora I, Gutiez J, Quiroga JA, Ramón y Cajal S, Oliva H, Compernolle C, Bartolomé J.
    Antiviral Res; 1987 Oct; 8(3):125-37. PubMed ID: 3501274
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP, Cornu C, Lens E, Lamy M, Geubel A.
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [Abstract] [Full Text] [Related]

  • 8. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
    Carreño V, Porres JC, Ruiz-Moreno M, Gutiez J, Bartolomé FJ.
    Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant leukocyte interferon treatment of chronic hepatitis B.
    Dusheiko G, Dibisceglie A, Bowyer S, Sachs E, Ritchie M, Schoub B, Kew M.
    Hepatology; 1985 Jan; 5(4):556-60. PubMed ID: 4018728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ, Craig PI, Cooksley WG, Bye WA, Bilous M, Grierson JM, Nightingale BN, Burnett L, Hensley WJ, Batey RG.
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
    Brook MG, Main J, Yap I, Chan G, Karayiannis P, Crossey M, Thomas HC.
    Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
    [Abstract] [Full Text] [Related]

  • 18. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC.
    Ann Intern Med; 1988 Jul 15; 109(2):95-100. PubMed ID: 3289433
    [Abstract] [Full Text] [Related]

  • 19. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH, Beames MP, Kuhns MC, Hoofnagle JH, Di Bisceglie AM.
    Am J Gastroenterol; 1996 Nov 15; 91(11):2323-8. PubMed ID: 8931411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.